Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
22-Dec-2014LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionMura, M; Hopkins, TG; Michael, T; Abd-Latip, N; Weir, J, et al
18-Mar-2014A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancerGlasspool, RM; Brown, R; Gore, ME; Rustin, GJS; McNeish, IA, et al
29-May-2014Molecular physiology monitoring of ovarian cancer ex vivo.Fotopoulou, C; Gorgy, T; Paterson, A; Petkos, K; Cunnea, P, et al
1-Dec-2014Introduction to managing patients with recurrent ovarian cancerGabra, H